is mounjaro a glp 1 agonist Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), major breakthrough for the treatment of obesity Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

Todays DietitianVol

Risk of bias: all four RCTs were rated low risk by RoB2 (with some concerns for open-label outcome ascertainment in three trials, a domain-specific issue that does not alter the overall RoB2 category from low)

More on, ADA and AACE Guidelines prefer GLP1RA over DPP4i for patients with established ASCVD or indicato...

GLP-1 and GIP receptor agonists are groundbreaking treatments originally developed for diabetes, now also employed in managing obesity

The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer

Counting the days since you had your last poop? Oof